Tsukada T
Division of Hematologic Research, Toranomon Hospital.
Rinsho Ketsueki. 1994 May;35(5):469-74.
Scientific and Standardization Committee (SSC) of International Thrombosis and Hemostasis has acted its activity since 1955 for establishing international concept on terminology, methodology in the fields of blood platelets, coagulation and fibrinolysis. Among the reports from 15 sub-committee in 1993 meeting, some clinically interesting topics are reported. In von Willebrand factor (vWF) Subcommittee, new classification of von Willebrand disease including new variant of VFW which shows defect on factor VIII binding capacity, is proposed. In Control of Anticoagulation Subcommittee, the necessity of coagulation monitoring during low molecular weight heparin (LMWH) administration was discussed. For prophylaxis use, monitoring is unnecessary except patients having renal failure or high-low body weight. For the treatment of venous thrombosis once or twice monitoring every 10 days would be necessary. In Lupus anticoagulant (LA)/phospholipid dependent antibodies Subcommittee, results of 3rd international survey for LA sent to 38 laboratories in 16 countries including Japan were reported. Most laboratory used APTT and dRVVT simultaneously as screening tests. Sensitivity and specificity of confirmatory test for LA are compared; the best one was Staclot LA and the second was DVVT.
国际血栓形成与止血科学标准化委员会(SSC)自1955年起开展活动,旨在确立血小板、凝血和纤维蛋白溶解领域术语及方法的国际概念。在1993年会议上15个小组委员会的报告中,有一些具有临床意义的主题被报道。在血管性血友病因子(vWF)小组委员会中,提出了血管性血友病的新分类,包括一种显示因子VIII结合能力缺陷的血管性血友病新变体。在抗凝控制小组委员会中,讨论了低分子量肝素(LMWH)给药期间凝血监测的必要性。对于预防性使用,除了肾衰竭或体重过高或过低的患者外,无需进行监测。对于静脉血栓形成的治疗,每10天进行一到两次监测是必要的。在狼疮抗凝物(LA)/磷脂依赖性抗体小组委员会中,报告了发送给包括日本在内的16个国家38个实验室的第三次LA国际调查结果。大多数实验室同时使用活化部分凝血活酶时间(APTT)和稀释的蝰蛇毒时间(dRVVT)作为筛查试验。比较了LA确证试验的敏感性和特异性;最佳的是Staclot LA,其次是稀释蝰蛇毒时间(DVVT)。